All things Diabetes Flashcards

1
Q

What features would raise suspicion of diabetes mellitus?

A

Thirst
Toileting
Tiredness
Thin
+ blurred vision, infections in T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What history features point towards T1DM over T2DM?

A

Younger
Family history of autoimmune disease
Ketosis (fruity breath, DKA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What blood glucose levels would indicate diabetes mellitus?

A

Random >11.1 mmol/L
Fasting: >7mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What Hb1AC values suggest…
prediabetes
diabetes

A

prediabetes: 42-47
diabetes: >=48

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can Hb1AC be used for diagnosis of diabetes mellitus?

A

>=48 can diagnose T2DM
NOT DIAGNOSTIC IN T1DM, YOUNG, PREGNANT, HAEMOGLOBINOPATHIES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do you need to diagnose Diabetes mellitus?

A

Either
1 high blood glucose + symptoms
2 high blood glucose on two separate occasions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In what circumstances would a C-peptide or autoantibody titre be useful in diabetes mellitus?

A

Confirm T1DM if atypical or monogenic presentation
C-peptide titres would be low
Anti-GAD/islet antibodies would be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the treatment for T1DM?

A

Insulin therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment pathway for type 2 diabetes mellitus?

A
  1. Metformin
  2. Metformin + option*
  3. Metformin + 2 options
  4. Metformin + sulfonylurea + GLP-1 mimetic if BMI >35 and above 3 drugs not working

Options: Sulfonylureas (glicazide)/SGLT-2 inhibitor (flozins)/pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

At what point would you escalate drug management of T2DM>

A

Hb1AC >=58

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Regarding GLP-1 as part of last line therapy of T2DM, what criteria needs to be met to continue on it

A

Reduction in Hb1AC by 11 AND at least 3% body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What cardiovascular management should be considered in diabetes mellitus?

A

ACEi (-prils) or ARBs (-sartans) for HTN
low dose statin if Q-risk score >10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What would you suspect in a patient with diabetic symptoms without ketosis who was under 25 with a diabetic family history?

A

Maturity onset Diabetes of the Young
Responsive to sulfonylurea monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the side effects of metformin?

A

Gastrointestinal upset

Lactic Acidosis is rare but fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Regarding metformin’s action, which common drugs do you need to watch for?

A

Alcohol: hypoglycaemia, lactic acidosis

B-blockers: Can mas hypoglycaemia

Ketotifen (anti-allergic): can reduce platelet count

Topiramate: Increase metformin action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which T2DM drugs cause hypoglycaemia?

A

Sulfonylureas (glicazide, glibenclamide)

Low risk in GLP-1 mimetics

17
Q

Which diabetic drugs induce weight loss?

A

SGLT-2 inhibitors (-gliflozins)

GLP-1 mimetic (exenatide, liraglutide)

18
Q

Which diabetic drugs induce weight gain?

A

Thiazolinediones (pioglitazone)

Sulfonylurea (glicazide)

19
Q

Which diabetic drugs do not affect weight?

A

Metformin

DPP4-inhibitors (glitpins)

20
Q

Which diabetic drugs is most associated with glucosuria?

A

SGLT-2 inhibitors (gliflozins)

21
Q

Which diabetic drug is most associated with fluid retetion?

A

Thiazolidinediones (pioglitazone)

22
Q

Gliptins are part of x class of drug

Flozins are y kind of drugs

A

X: DPP-4 inhibitors

Y: SGLT-2 inhibitors

23
Q

What is the first line HTN therapy for a diabetic?

A

ACE inhibitor (ramipril, lisinopril)

24
Q

Regarding insulin therapy, what should

Be given foodwise if there’s a hypo

Be given to patients on commencing therapy

Be changed when sick

be calculated for a rough corrective dose when sick

A

10-20mg short acting carb (glass sugary drink, 3 glucose tabs)

Glucagon kit for emergency hypos

DONT CHANGE ANYTHING

1/6 daily dose (up to 15 units)

25
Q

What is the mechanism of action of

Biguanides (metformin)

Sulfonylurea (gliciazide)

SGLT2 inhibitors (flozin)

DPP4 inhibitors (gliptins)

GLP-1 mimetics (exenatide, liraglutide)

Thiazolinedione (pioglitazone)

A

Met: Decrease gluconeogenesis, increase peripheral glucose usage

SU: increased insulin excretion

SGLT2: Blocks reabsorption by kidneys, promotes urine excretion

DPP4: Inhibits DPP4 mediated destruction of incretin

GLP-1: Increases insulin and reduces glucagon secretion, slows gastric emptying

Thiazolinedione: Increases glucose uptake into muscle and adipose tissue

26
Q

what T2DM medication is associated with

Bladder cancer

fractures

Liver impairment

Fluid retetion

A

Thiazolinediones

Contraindicated in heart failure

27
Q

What are the Hb1AC targets when on therapy?

A

Lifestyle +/- metformin: 48

Risen past 48 or on hypoglycaemic: 53

28
Q

In diabetic therapy, when must an SGLT-2i be added?

A

Established or risk >10% CHD

Heart failure

29
Q

If metformin was contraindicated in a patient, what therapy would you give?

A

CHD/HF: SGLT-2

No CHD/HF: DPP4 (Gliptin)/ SU (gliciazide)/ Thiazolinedione (pioglitazone)

30
Q

When is GLP-1 therapy considered

A

Inadequate cover by triple therapy and either

BMI >35 + psychological/medical problems associated with obesity

BMI <35 but insulin would be an occupational hazard

31
Q

How does Ramadan affect T2DM management

A

Sunrise (Suhoor): 1/3 metformin dose, long acting carb meal

Sunset (Iftar): majority metformin, gliciazide dose

32
Q

How does diabetes mellitus affect haivng a licence for

Group 1 vehicles (cars, motorbikes)

Group 2 (HGV)

A

Group 1

Insulin dependent or hypoglycaemics (SU, liraglutide): no more than 1 hypo needing assistance

Group 2

No severe episodes in 12 months

Full hypo awareness + bidaily monitoring data for past 3 months